News for Helix BioPharma Corp. (HBPCF)

Helix BioPharma Corp. reported earnings results for the first quarter ended October 31, 2023. For the first quarter, the company reported net loss was CAD 1.25 million compared to CAD 1.61 million a...

August 21, 2023 Press Release 2704, 401 Bay Street Toronto, M5H 2Y4 Ontario Tel: 905-841-2300 ...

Insider brings you the rundown of the latest market news investors and traders are keeping an eye on.

Read Helix BioPharma (TSE:HBP) Stock Price Passes Above Fifty Day Moving Average of $0.22 at ETF Daily News

Read Helix BioPharma (TSE:HBP) Share Price Crosses Above 50-Day Moving Average of $0.21 at ETF Daily News

Read Helix BioPharma (TSE:HBP) Share Price Crosses Above 50-Day Moving Average of $0.21 at ETF Daily News

Read Helix BioPharma (TSE:HBP) Shares Cross Above Fifty Day Moving Average of $0.20 at ETF Daily News

Read Helix BioPharma (TSE:HBP) Shares Pass Below 50 Day Moving Average of $0.21 at ETF Daily News

Read Helix BioPharma (TSE:HBP) Stock Passes Below Fifty Day Moving Average of $0.21 at ETF Daily News

Read Helix BioPharma (TSE:HBP) Stock Crosses Below 50-Day Moving Average of $0.22 at ETF Daily News

/PRNewswire/ -- The "Cervical Dysplasia Market Research Report by Diagnostics Type, by Treatment Type, by End User, by Region - Global Forecast to 2027 -...